Update shared on03 Sep 2025
Fair value Increased 2.64%Chemed’s modest price target increase to $582.25 reflects stable sentiment, as core metrics like future P/E and revenue growth remain virtually unchanged.
What's in the News
- Increased equity buyback authorization by $300 million, bringing total to $2.75 billion.
- Raised quarterly dividend by 20% to 60 cents per share.
- Lowered 2025 earnings guidance to $22.00–$22.30 per diluted share, down from prior $24.95–$25.45 range.
- Repurchased 75,000 shares for $42.9 million; total buybacks now 11,053,146 shares (62.45%) for $2.27 billion under ongoing program.
Valuation Changes
Summary of Valuation Changes for Chemed
- The Consensus Analyst Price Target has risen slightly from $567.25 to $582.25.
- The Future P/E for Chemed remained effectively unchanged, moving only marginally from 25.81x to 26.21x.
- The Consensus Revenue Growth forecasts for Chemed remained effectively unchanged, moving only marginally from 5.0% per annum to 5.1% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.